Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster Display session

35P - Racial Disparities in Diagnosis, Histological Type,Treatment and Survival in Ovarian Cancer Patients in the US from 1992 to 2018: SEER-based Analysis.

Date

17 Jun 2022

Session

Poster Display session

Presenters

Eman Zin Eldin

Citation

Annals of Oncology (2022) 33 (suppl_5): S395-S401. 10.1016/annonc/annonc918

Authors

E.I. Zin Eldin

Author affiliations

  • MFM-SRP, Menoufia/EG

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Abstract 35P

Background

Ovarian malignancies are the 7th diagnosed malignancy and the 8th cause of death in females worldwide. Ovarian cancer includes a great heterogeneous group of neoplasms that differs in histological type, pathological stage, risk factors, prognosis, and treatment. Racial disparities in incidence, treatment, and mortality in cancers exist globally. With Surveillance, Epidemiology, and End Results (SEER) program in place, detection of these disparities would be feasible. herein racial disparities in ovarian cancer are analyzed.

Methods

Using SEER*Stat 8.3.9 program and then Case listing session and extracting data from Incidence - SEER Research Data, 13 Registries, Nov 2020 Sub (1992-2018). Patients with malignant behavior and known age diagnosed between 1992 to 2018 and site recode ICD-O-3 WHO 2008(ovary) were included; patients with incomplete data were excluded. Descriptive analysis and Kaplan Miere survival are done using IBM SPSS Statistics 25.

Results

46854 patients were included in the analysis, Non-Hispanic (NH) white race was 69.9% of them followed by the Hispanic group represents 11.8%. There was a great association between races and histology; eta was 0.06, Most predominant histological type was non-invasive low-grade serous carcinoma by 22.9%,20.7%,18.9% in NH white, Hispanic, NH black respectively. 2nd most predominant was Serous tubal intraepithelial carcinoma in NH American Indian/Alaska Native and NH Asian or Pacific Islander by 24.0% and 18.8% respectively. Kaplan Meier analysis revealed the best median survival time of 78 months (95%CI 70.89:85.12, SE 3.63) in NH Asian or Pacific Islander group, followed by Hispanic (All Races) with 56 months (95%CI 52.09:59.91, SE 1.99). The worst survival time was noticed in Non-Hispanic Black with a median survival time of 27 months (95%CI 24.95:29.05 SE 1.04). Log Rank p-value =0.001. Regarding Racial association with staging; eta was 0.04 and distant stage was predominant in all races 68.0%,68.7%,57.7%,67.1%,62.6% for NH White, NH Black, NH Asian or Pacific Islander, NH American Indian/Alaska Native, Hispanic (All Races) respectively.

Conclusions

Our analysis goes along with present literature regarding racial disparities.

Legal entity responsible for the study

The author.

Funding

Has not received any funding.

Disclosure

The author has declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.